End-to-End Machine Learning-Driven Design of Targeted Monoclonal Antibodies

Exclusively Licensed

Researchers

Matthew Walsh / Rajmonda Caceres / Rafael Jaimes / Lin Li / Esther Wolf / Will Spaeth / Leslie Shing / Tristan Bepler

Departments: Lincoln Laboratory
Technology Areas: Artificial Intelligence (AI) and Machine Learning (ML) / Drug Discovery and Research Tools: Antibodies / Therapeutics: Proteins & Antibodies
Impact Areas: Healthy Living

  • end-to-end machine learning-driven design of proteins
    United States of America | Pending
  • end-to-end machine learning-driven design of proteins
    Singapore | Pending

License this technology

Interested in this technology? Connect with our experienced licensing team to initiate the process.

Sign up for technology updates

Sign up now to receive the latest updates on cutting-edge technologies and innovations.

More Technologies